Drug-resistant tuberculosis in the Philippines.
Rivera
A B
AB
Tupasi
T E
TE
Balagtas
E D
ED
Cardano
R C
RC
Baello
B Q
BQ
Quelapio
I D
ID
Villa
L A
LA
Pascual
L G
LG
Co
V M
VM
Mantala
M J
MJ
D000995:Antitubercular Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018432:Drug Resistance, Multiple; D004977:Ethambutol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015994:Incidence; D007538:Isoniazid / Q000008:administration & dosage; D008297:Male; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010679:Philippines / Q000453:epidemiology; D011718:Pyrazinamide / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000453:epidemiology*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin